Lapatinib in Combination With Weekly Paclitaxel in Patients With ErbB2 Amplified Advanced Gastric Cancer

NCT00486954 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

273

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms, Gastrointestinal Tract

Interventions

DRUG: Lapatinib
DRUG: Paclitaxel

Sponsor

GlaxoSmithKline